Gaucher's disease


Also found in: Dictionary, Medical, Legal, Encyclopedia, Wikipedia.
  • noun

Words related to Gaucher's disease

a rare chronic disorder of lipid metabolism of genetic origin

References in periodicals archive ?
It also reviews key players involved in the therapeutic development for Gaucher's Disease and special features on late-stage and discontinued projects.
Companies involved in therapeutics development for Gaucher's Disease and discussed in this research include Amicus Therapeutics, Inc.
In the new study, the researchers revealed how the widely available prescription drugs diltiazem, verapamil, and in some cases dantrolene, acted on cells from patients with Gaucher's disease.
Acute bilateral symmetrical pathologic fractures of the lateral tibial plateaus in a patient with Gaucher's disease.
The recent arrival on the market of a modified glucocerebrosidase (Ceredase) for Gaucher's Disease and last year's approval of PEG-adenosine deaminase for severe combined immunodeficiency disease illustrate the growing capabilities of the pharmaceutical industry to provide endogenous compounds that patients are lacking.
A snapshot of the global therapeutic scenario for Gaucher's Disease.
Brady first proposed enzyme-replacement therapy for Gaucher's disease 25 years ago.
Tiscornia's project is entitled "Development of an induced pluripotent stem cell model of neuronopathic Gaucher's Disease for investigating mechanisms of pathogenesis and small molecule testing.
Gaucher's disease, an inherited enzyme deficiency, affects more than 20,000 people in the United States and is especially prevalent among Jews of Eastern European ancestry.
Our clinical trial report, "Gaucher's Disease Global Clinical Trials Review, H2, 2012" provides data on the Gaucher's Disease clinical trial scenario.
Oxford GlycoSciences plc (LSE: OGS) today announced that OGT 918 (Vevesca(TM)) has been designated as an Orphan Medicinal Product by the European Commission for the treatment of Gaucher's Disease.
The finding will improve genetic counselingfor victims of the the most serious forms of Gaucher's disease, which is caused by the enzyme deficiency, report the researchers in the March 5 NEW ENGLAND JOURNAL OF MEDICINE.
Global Markets Direct's, 'Gaucher's Disease - Pipeline Review, H1 2012', provides an overview of the Gaucher's Disease therapeutic pipeline.